• GSK and Vir Biotechnology will focus on making drugs and vaccines against COVID-19
• Vir Biotechnology will continue it’s partnership with other companies
• Shares of Vir Biotechnology rose by 30 percent on the Nasdaq
Pharma giant GlaxoSmithKline based out of London, has decided to make an equity investment worth $250 million in a small biotechnology company which is bas....
Tags : Gsk, vir biotechnology, GlaxoSmithKline, coronavirus medicine, pharmaceutical news, medical news, gsk pharma,